Neuroendocrine Neoplasm
Oncology·MeSH: Neuroendocrine Tumors
Prevalence
30.0 / 100K
3 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 1(2)
Phase 1/Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Neuroendocrine Neoplasm?
BioSniper tracks 3 drugs in development for Neuroendocrine Neoplasm across 2 companies.
How many clinical trials target Neuroendocrine Neoplasm?
There are 2 clinical trials targeting Neuroendocrine Neoplasm tracked by BioSniper.
What is the prevalence of Neuroendocrine Neoplasm?
The estimated prevalence of Neuroendocrine Neoplasm is approximately 30.0 per 100,000 population.
Deep-dive into Neuroendocrine Neoplasm
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis